Michel D Ferrari Selected Research

Migraine with Aura (Familial Hemiplegic Migraine)

1/2022	CaV2.1 channel mutations causing familial hemiplegic migraine type 1 increase the susceptibility for cortical spreading depolarizations and seizures and worsen outcome after experimental traumatic brain injury.
10/2020	Anti-migraine Calcitonin Gene-Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice.
1/2019	Phase clustering in transcranial magnetic stimulation-evoked EEG responses in genetic generalized epilepsy and migraine.
1/2017	Cortical Spreading Depression Causes Unique Dysregulation of Inflammatory Pathways in a Transgenic Mouse Model of Migraine.
8/2015	Abnormal synaptic Ca(2+) homeostasis and morphology in cortical neurons of familial hemiplegic migraine type 1 mutant mice.
5/2015	Plasma metabolic profiling after cortical spreading depression in a transgenic mouse model of hemiplegic migraine by capillary electrophoresis--mass spectrometry.
4/2015	From migraine genes to mechanisms.
2/2015	Migraine mutations impair hippocampal learning despite enhanced long-term potentiation.
1/2015	Migraine prophylaxis, ischemic depolarizations, and stroke outcomes in mice.
1/2015	Familial hemiplegic migraine type-1 mutated cav2.1 calcium channels alter inhibitory and excitatory synaptic transmission in the lateral superior olive of mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michel D Ferrari Research Topics

Disease

91	Migraine Disorders (Migraine) 01/2022 - 01/2002
36	Migraine with Aura (Familial Hemiplegic Migraine) 01/2022 - 09/2003
16	Epilepsy (Aura) 01/2021 - 01/2004
14	Headache (Headaches) 01/2020 - 02/2005
12	Pain (Aches) 01/2015 - 01/2002
9	Cluster Headache (Cluster Headaches) 02/2022 - 11/2013
6	Stroke (Strokes) 12/2019 - 02/2006
5	Ischemic Stroke 10/2020 - 01/2012
4	Migraine without Aura (Common Migraine) 01/2021 - 11/2008
4	CADASIL 01/2018 - 12/2010
3	Infarction (Infarctions) 10/2020 - 01/2012
3	Leukoencephalopathies 01/2018 - 11/2016
3	Ataxia (Dyssynergia) 01/2009 - 12/2006
2	Seizures (Absence Seizure) 01/2022 - 01/2009
2	5 Familial Hemophagocytic Lymphohistiocytosis 01/2021 - 06/2016
2	visual snow syndrome 01/2021 - 07/2019
2	Prescription Drug Overuse 01/2020 - 01/2019
2	Disease Progression 01/2018 - 03/2002
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2018 - 12/2017
2	Cerebral Small Vessel Diseases 01/2018 - 12/2012
2	Neuroinflammatory Diseases 08/2017 - 06/2017
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2017 - 01/2016
2	Inflammation (Inflammations) 01/2016 - 02/2013
2	Cerebellar Ataxia (Dysmetria) 03/2014 - 10/2012
2	Photophobia (Light Sensitivity) 08/2013 - 12/2008
2	Headache Disorders (Headache Syndromes) 07/2012 - 06/2005
2	Muscle Weakness 04/2007 - 03/2002
1	Brain Edema (Cerebral Edema) 01/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Ischemia 10/2020
1	Brain Ischemia (Cerebral Ischemia) 10/2020
1	Transient Ischemic Attack 10/2020
1	Syncope (Fainting) 01/2020

Drug/Important Bio-Agent (IBA)

24	voltage-dependent calcium channel (P-Q type)IBA 01/2022 - 03/2004
11	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2006
9	Tryptamines (Triptans)IBA 01/2020 - 01/2003
9	Calcium Channels (Calcium Channel)IBA 01/2017 - 06/2002
8	Pharmaceutical PreparationsIBA 01/2019 - 09/2004
8	Pain-FreeIBA 07/2012 - 02/2005
7	Glutamic Acid (Glutamate)FDA Link 01/2021 - 06/2007
7	Biological ProductsIBA 01/2020 - 09/2005
7	Retinaldehyde (Retinal)IBA 01/2018 - 06/2008
7	frovatriptan (Allegro)FDA Link 07/2012 - 06/2010
6	Calcitonin Gene-Related PeptideIBA 10/2020 - 12/2008
5	Valproic Acid (Depakote)FDA LinkGeneric 01/2022 - 01/2010
5	zolmitriptan (Zomig)FDA Link 05/2012 - 12/2008
4	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2022 - 10/2011
4	Type A Botulinum Toxins (Botox)FDA Link 01/2022 - 01/2019
4	Analgesics (Analgesic Drugs)IBA 01/2021 - 06/2005
4	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2021 - 01/2020
4	Sumatriptan (Imigran)FDA LinkGeneric 01/2020 - 01/2002
4	Neurotransmitter Agents (Neurotransmitter)IBA 06/2017 - 09/2008
4	Proteins (Proteins, Gene)FDA Link 06/2016 - 09/2012
4	Adenosine Triphosphatases (ATPase)IBA 09/2012 - 09/2003
4	almotriptan (Axert)FDA Link 07/2012 - 01/2002
4	rizatriptan (Maxalt)FDA Link 05/2012 - 01/2002
3	Topiramate (Topamax)FDA LinkGeneric 01/2022 - 01/2010
3	erenumabIBA 04/2021 - 11/2018
3	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2014
3	salicylhydroxamic acid (SHAM)IBA 10/2019 - 01/2018
3	Lamotrigine (Lamictal)FDA LinkGeneric 07/2019 - 08/2014
3	telcagepantIBA 02/2016 - 12/2008
3	Hormones (Hormone)IBA 01/2015 - 02/2013
3	Vasoconstrictor AgentsIBA 10/2010 - 01/2004
3	PotassiumIBA 11/2008 - 06/2004
3	Sodium Channels (Sodium Channel)IBA 07/2008 - 07/2005
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 01/2015
2	Monoclonal AntibodiesIBA 01/2022 - 01/2016
2	fremanezumabIBA 01/2022 - 01/2019
2	Q-Type Calcium Channels (Q-Type Calcium Channel)IBA 01/2022 - 04/2014
2	Illicit Drugs (Recreational Drugs)IBA 01/2021 - 01/2019
2	Vasodilator Agents (Vasodilators)IBA 01/2020 - 01/2015
2	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 11/2018 - 12/2008
2	AndrogensIBA 01/2018 - 10/2009
2	Capsaicin (Zostrix)FDA Link 01/2018 - 01/2015
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2018 - 02/2013
2	IronIBA 07/2017 - 12/2012
2	DNA (Deoxyribonucleic Acid)IBA 06/2016 - 05/2007
2	Purinergic P2X3 ReceptorsIBA 01/2013 - 08/2010
2	Voltage-Gated Sodium ChannelsIBA 07/2008 - 07/2005
2	eletriptan (Relpax)FDA Link 02/2008 - 01/2002
1	Hallucinogens (Psychedelics)IBA 01/2021
1	Psilocybin (Psilocibin)IBA 01/2021
1	A 7 (A-7)IBA 01/2021
1	Nitrous Oxide (Laughing Gas)IBA 01/2021
1	4-fluoroamphetamineIBA 01/2021
1	3-methylmethcathinoneIBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	c-Mer Tyrosine KinaseIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2021
1	rimegepant sulfateIBA 10/2020
1	olcegepantIBA 10/2020
1	galcanezumabIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020

Therapy/Procedure

10	Therapeutics 01/2022 - 02/2005
4	Vagus Nerve Stimulation 10/2020 - 01/2018
2	Lasers (Laser) 01/2015 - 01/2012
1	Injections 02/2022
1	Drug Therapy (Chemotherapy) 01/2020